Elravie Re2O Fine is the 50 mg presentation of Humedix’s human acellular dermal matrix (hADM) skin booster — freeze-dried human dermal tissue processed by L&C Bio’s Alloclean Technology to preserve the extracellular matrix. Humedix targets it at the under-eye area and neck lines, where a smaller ECM dose suits thin skin, as the companion to the 150 mg full-face Re2O. Reconstituted before injection; room-temperature storage until opened; professional use only.
What is Elravie Re2O Fine?
Elravie Re2O Fine is the 50 mg presentation of Humedix’s human acellular dermal matrix (hADM) skin booster. Like the 150 mg Re2O, it is freeze-dried human dermal tissue processed by L&C Bio’s Alloclean Technology so that cells and immunogenic factors are removed and the extracellular-matrix structure is preserved. Humedix lists the under-eye area and neck lines as its target zones — the thin-skinned areas where a smaller ECM dose is appropriate.
Re2O Fine or Re2O 150 mg — which one?
The two share the same tissue source and classification; the difference is dose and target area. Re2O (150 mg) is the full-face and neck product; Re2O Fine (50 mg) is aimed at the under-eye zone and neck lines. Humedix does not state a difference in particle size, so Lyderma does not claim one. For the eye area it sits alongside polynucleotide options such as Puri Eyes and Rejuran I, but supplies matrix rather than a signalling molecule.
| Elravie Re2O Fine | hADM 50 mg · under-eye and neck lines |
|---|---|
| Elravie Re2O | hADM 150 mg · full face and neck |
| Puri Eyes | PN 2 mg/mL · 1.1 mL · under-eye |
| Rejuran I | Low-viscosity PN · 1 mL · eye area |
What do clinics use Re2O Fine for?
It is positioned for under-eye skin quality and neck lines — areas where texture, crepiness and density matter and where a lower ECM dose is wanted. Reconstitution volume, needle choice and session count are not published by Humedix; preparation and technique follow the product instructions and the treating clinician’s judgement.
Commonly selected for
- Under-eye crepiness and density loss
- Horizontal neck lines
- Patients already treated with Re2O 150 mg on the face
- Premium eye-area programmes beyond polynucleotides
How is Re2O Fine supplied and stored?
One 50 mg freeze-dried unit per box, reconstituted before use. Store at room temperature (1–30 °C) until the package is opened, per Humedix. Supplied for professional use only.
Reviewed against publicly available manufacturer information. Indications, dosing and technique are product-specific per the manufacturer’s labeling and are decided by the treating clinician.
Specifications
| Brand | Elravie® Re2O Fine (Humedix) |
|---|---|
| Distributor / brand owner | Humedix Co., Ltd. — Huons Group (South Korea) |
| Tissue processor | L&C Bio Co., Ltd. (South Korea), Alloclean Technology |
| Origin | South Korea |
| Active | Human acellular dermal matrix 50 mg |
| Format | Freeze-dried unit in syringe |
| Presentation | 1 unit per box |
| Areas | Under-eye · neck lines |
| Classification | Supplied in Korea as a human-tissue product |
| Administration | By a qualified medical professional only; reconstitution and technique per the product instructions |
| Storage & handling | Room temperature 1–30 °C until opened (manufacturer) |
| Composition | Human acellular dermal matrix (hADM) 50 mg, freeze-dried human tissue |
Frequently asked questions
What is Elravie Re2O Fine used for?
For the under-eye area and neck lines, per Humedix — thin-skinned zones where a 50 mg dose of acellular dermal matrix is appropriate.
How does it differ from Re2O 150 mg?
Same hADM tissue and processing; Re2O Fine is 50 mg for the under-eye and neck lines, while Re2O is 150 mg for the full face and neck. Humedix does not state a particle-size difference.
Is it a polynucleotide product?
No. It contains no PN or HA. It is decellularised human dermal matrix that supplies extracellular-matrix components to the skin.
How is it prepared?
The freeze-dried 50 mg unit is reconstituted before injection. Humedix does not publish a fixed diluent volume or session count; the treating clinician follows the product instructions.
How should it be stored?
At room temperature between 1 and 30 °C until the package is opened. One unit per box.